Valpotime CR 200 Tablet contains Sodium Valproate 200mg, a controlled-release antiepileptic agent used for the management of epilepsy, seizure disorders, and bipolar disorder. It stabilizes electrical activity in the brain, reducing the frequency and severity of seizures and helping control mood swings.
Belonging to the neurology and psychiatry segment, Valpotime CR 200 is widely prescribed by neurologists and psychiatrists in hospitals, clinics, and mental health centers. Its controlled-release formulation ensures steady therapeutic levels, improving patient compliance and reducing side effects.
Sodium Valproate acts by modulating neurotransmitters in the central nervous system, providing effective symptomatic relief for patients with epilepsy, bipolar disorder, and related neurological conditions.
For PCD pharma franchise partners, distributors, exporters, and third-party manufacturers, Valpotime CR 200 Tablet offers a profitable B2B opportunity. Its high prescription rate and essential therapeutic use ensure a stable demand and strong market presence across India.
Common side effects may include nausea, vomiting, dizziness, drowsiness, or mild gastrointestinal discomfort. Rare but serious effects may include liver toxicity, pancreatitis, severe allergic reactions, or blood disorders. Seek medical attention if you experience jaundice, persistent vomiting, or unusual bruising.
Valpotime CR 200 Tablet is indicated for the treatment of epilepsy, seizure disorders, and bipolar disorder. It helps control generalized, partial, and absence seizures, and can stabilize mood in patients with bipolar disorder.
Take Valpotime CR 200 Tablet exactly as prescribed, preferably with food to reduce gastrointestinal irritation. Do not discontinue suddenly, as this may trigger seizures or mood instability. Inform your doctor if you have liver disease, kidney problems, or are pregnant or planning pregnancy.
Store Valpotime CR 200 Tablet in a cool, dry place below 25°C, away from sunlight and moisture. Keep out of reach of children.